Correction: A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer

Affiliations

¹ Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
² Department of Surgery, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan.
³ Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Osaka, Japan.
⁴ Division of Molecular Diagnosis and Cancer Prevention, Saitama Cancer Center, Ina, Saitama, Japan.
⁵ Division of Gastroenterology, Chiba Cancer Center, Chiba, Chiba, Japan.
⁶ Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan.
⁷ Department of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Sapporo, Hokkaido, Japan.
⁸ Department of Surgery and Science, Graduate School of Medical Science, Kyushu University, Fukuoka, Fukuoka, Japan.
⁹ Department of Frontier Science for Cancer and Chemotherapy, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
¹⁰ Scientific Affairs Division, Clinical Affairs, Sysmex Corporation, Kobe, Hyogo, Japan.
¹¹ Department of Biostatistics, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan.
¹² Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan. tyoshino@east.ncc.go.jp.

^# Contributed equally.

Published Erratum

Hideaki Bando et al. Br J Cancer. 2020 Apr.

. 2020 Apr;122(8):1271.

doi: 10.1038/s41416-020-0766-1.

¹ Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
² Department of Surgery, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan.
³ Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Osaka, Japan.
⁴ Division of Molecular Diagnosis and Cancer Prevention, Saitama Cancer Center, Ina, Saitama, Japan.
⁵ Division of Gastroenterology, Chiba Cancer Center, Chiba, Chiba, Japan.
⁶ Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan.
⁷ Department of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Sapporo, Hokkaido, Japan.
⁸ Department of Surgery and Science, Graduate School of Medical Science, Kyushu University, Fukuoka, Fukuoka, Japan.
⁹ Department of Frontier Science for Cancer and Chemotherapy, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
¹⁰ Scientific Affairs Division, Clinical Affairs, Sysmex Corporation, Kobe, Hyogo, Japan.
¹¹ Department of Biostatistics, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan.
¹² Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan. tyoshino@east.ncc.go.jp.

^# Contributed equally.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer.
Bando H, Kagawa Y, Kato T, Akagi K, Denda T, Nishina T, Komatsu Y, Oki E, Kudo T, Kumamoto H, Yamanaka T, Yoshino T. Bando H, et al. Br J Cancer. 2019 May;120(10):982-986. doi: 10.1038/s41416-019-0457-y. Epub 2019 Apr 24. Br J Cancer. 2019. PMID: 31015557 Free PMC article.